Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 10013
  • 10014
  • 10015
  • …
  • ›
  • »

2025-07-09

Arco Vara Has a New Chairman of the Supervisory Board

2025-07-09

Omega II AB announces outcome and further extends the acceptance period for the offer to the shareholders of Fortnox AB (publ)

2025-07-09

The Environmental Group Wins $1.9m Order for Innovative New PFAS Treatment Plant

2025-07-09

Seetel partners with Canadian firm to expand global energy storage reach

2025-07-09

Azelis Strengthens Its Footprint in Italy With the Acquisition of Azienda Chimica e Farmaceutica (′ACEF′)

2025-07-09

Research: Shenwan Hongyuan Foresees 20 Stocks to Join Southbound Stock Connect in Sep, Incl. IFBH & ZHOU LIU FU

2025-07-09

Research: Shenwan Hongyuan Names Potential Candidates for Inclusion in Southbound Stock Connect List in Sep (Table)

2025-07-09

Coca-Cola FEMSA declares $0.9877 dividend

2025-07-09

Victory Square Technologies Inc.: Victory Square Technologies Reports Q1 2025 Financial Results and Provides Strategic Update

2025-07-09

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

2025-07-09

First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

2025-07-09

Wednesday’s HotCopper trends: Viridis PFS, Arizona Lithium raise | July 9

  • «
  • ‹
  • …
  • 10013
  • 10014
  • 10015
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 08/May/2026 15:30:26
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies